Trichomoniasis is venereal, that is, sexually transmitted, a disease that develops due to the penetration of the vaginal Trichomonas into the genitourinary system, one of the varieties of microorganisms of the genus Trichomonas. In the human body, three types of trichomonas – vaginal, in the oral cavity and the digestive tract. It is the vaginal trichomonas, the most common and pathogenic. The site of its localization becomes the mucous membrane of the vagina, ectocervix, excretory ducts of large glands of the vestibule, urethra, bladder, and in adverse circumstances and the cavity of the uterus, fallopian tubes.
Treatment of trichomoniasis is usually applicable to women who have an infection more often than men. However, the corresponding diagnosis in a woman means the need to be examined and undergo therapy for her man.
Treatment of trichomoniasis is exclusively etiotropic, that is, aimed at eliminating the cause, the causative agent. The course of medications is prescribed after regular menstruation and usually lasts three full cycles. Since trichomoniasis is often accompanied by concomitant infection and inflammation of the mucous genitalia, the treatment is the administration of a wide range of drugs to eliminate both trichomonads, and concomitant infection, and inflammation. Its basis for several decades is metronidazole in high doses and various forms. Local treatment in the form of vaginal tablets and suppositories is considered ineffective, as Trichomonas affect not only the mucous membrane of the vagina but also the Bartholin glands, the urethra.